VFO
DGX icon

Virtus Family Office’s Quest Diagnostics DGX Stock Holding History

Virtus Family Office’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,391
Closed -$1.65M – 48
2024
Q1 		$1.65M Hold
12,391
– – 2.63% 17
2023
Q4 		$1.71M Buy
12,391
+206
+2% +$27.1K 2.86% 19
2023
Q3 		$1.48M Buy
12,185
+2,120
+21% +$282K 2.7% 18
2023
Q2 		$1.41M Buy
10,065
+1,474
+17% +$203K 2.62% 15
2023
Q1 		$1.22M Buy
8,591
+15
+0.2% +$2.15K 2.4% 18
2022
Q4 		$1.34M Buy
8,576
+1,585
+23% +$228K 3% 11
2022
Q3 		$858K Buy
+6,991
New +$921K 2.19% 19

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Virtus Family Office's DGX Position: Q2 2024 in Review

Virtus Family Office sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 12,391 shares — an estimated $1.65M sold.

Virtus Family Office first reported a position in DGX in Q3 2022 and held it in 7 quarters. The position peaked at $1.71M in Q4 2023. 838 funds tracked by Wall St. Rank hold DGX as of Q2 2024.

  • Virtus Family Office reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
  • Virtus Family Office sold 12,391 Quest Diagnostics shares in Q2 2024, an estimated $1.65M.
  • Virtus Family Office first reported a position in Quest Diagnostics in Q3 2022 and held it in 7 quarters.
  • Virtus Family Office's Quest Diagnostics position peaked at $1.71M in Q4 2023.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.

Based on Virtus Family Office's 13F filing for Q2 2024, filed 12 Aug 2024.